Skip to main content Help with accessibility Skip to main navigation

SOLRIAMFETOL HYDROCHLORIDE tablets (Sunosi®▼) for excessive daytime sleepiness in obstructive sleep apnoea

CCG Approval Status:

Date Added: 19 - Oct - 2020
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of SOLRIAMFETOL HYDROCHLORIDE tablets (Sunosi®▼) for excessive daytime sleepiness in obstructive sleep apnoea.